DrugDevLetter

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

DrugDevLetter

Feb 2, 2025, 04:34 | Science

Timothée Olivier: How many patients with advanced or metastatic cancer respond to immunotherapy

Timothée Olivier, Medical oncologist at the Oncology Division of Geneva University, shared his recent article…

Dec 16, 2024, 13:18 | Insight

Timothée Olivier: Randomized vs Real - World Evidence on the efficacy and toxicity of checkpoint inhibitors

Timothée Olivier shared a post on X: " 'RANDOMIZED versus REAL-WORLD EVIDENCE on the efficacy…

All: 2 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023